Literature DB >> 15944902

Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient.

M Elleder1, M Jerábková, A Befekadu, M Hrebícek, L Berná, J Ledvinová, H Hůlková, H Rosewich, N Schymik, B C Paton, K Harzer.   

Abstract

An infant presented with multifocal myoclonus and cyanotic hypoxemia immediately after birth, and severe feeding problems, a protein-losing enteropathy, massive ascites and grand-mal epilepsy marked his rapid downhill course, with death at 17 weeks. At 2 weeks, brain MRI revealed grey matter heterotopias in the parieto-occipital regions suggestive of a cortical morphogenetic disorder. In cultured skin fibroblasts, lipid storage and reduced activities of ceramidase, galactosylceramide beta-galactosidase and glucosylceramide beta-glucosidase were evident. Autopsy disclosed generalised lysosomal lipid storage with macrophages and adrenal cortex prominently affected. The pattern of stored lipids in cultured fibroblasts and in dewaxed spleen tissue blocks was compatible with a diagnosis of prosaposin (pSap) deficiency (pSap-d). Neuropathologically, there was a pronounced generalised neurolysosomal storage combined with a severe depletion of cortical neurons and extreme paucity of myelin and oligodendroglia. This pathology, in particular the massive neuronal loss, differed from that in other neurolipidoses and could be explained by the reduced hydrolysis of multiple sphingolipids and the loss of pSap's neurotrophic function. The absence of immunostainable saposins on tissue sections and the presence of a homozygous c.1 A > T mutation in the prosaposin gene confirmed the diagnosis. PSap-d may be an underdiagnosed condition in infants with severe neurological and dystrophic signs starting immediately after birth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944902     DOI: 10.1055/s-2005-865608

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  18 in total

1.  Serum prosaposin levels are increased in patients with advanced prostate cancer.

Authors:  Shahriar Koochekpour; Siyi Hu; Cruz Vellasco-Gonzalez; Ruiz Bernardo; Gissu Azabdaftari; Guodong Zhu; Haiyen E Zhau; Leland W K Chung; Robert L Vessella
Journal:  Prostate       Date:  2011-05-31       Impact factor: 4.104

Review 2.  Lysosomal storage disorders in the newborn.

Authors:  Orna Staretz-Chacham; Tess C Lang; Mary E LaMarca; Donna Krasnewich; Ellen Sidransky
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

Review 3.  The protective role of prosaposin and its receptors in the nervous system.

Authors:  Rebecca C Meyer; Michelle M Giddens; Brilee M Coleman; Randy A Hall
Journal:  Brain Res       Date:  2014-08-15       Impact factor: 3.252

Review 4.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

5.  Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.

Authors:  Siyi Hu; Nathalie Delorme; Zhenzhen Liu; Tao Liu; Cruz Velasco-Gonzalez; Jone Garai; Ashok Pullikuth; Shahriar Koochekpour
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

6.  The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations.

Authors:  Helena Poupetová; Jana Ledvinová; Linda Berná; Lenka Dvoráková; Viktor Kozich; Milan Elleder
Journal:  J Inherit Metab Dis       Date:  2010-05-20       Impact factor: 4.982

7.  Neurolysosomal pathology in human prosaposin deficiency suggests essential neurotrophic function of prosaposin.

Authors:  Jakub Sikora; Klaus Harzer; Milan Elleder
Journal:  Acta Neuropathol       Date:  2006-10-06       Impact factor: 17.088

8.  Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.

Authors:  Ying Sun; Matt Zamzow; Huimin Ran; Wujuan Zhang; Brian Quinn; Sonya Barnes; David P Witte; Kenneth D R Setchell; Michael T Williams; Charles V Vorhees; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2013-02-27       Impact factor: 6.150

9.  NFYB-1 regulates mitochondrial function and longevity via lysosomal prosaposin.

Authors:  Rebecca George Tharyan; Andrea Annibal; Isabelle Schiffer; Raymond Laboy; Ilian Atanassov; Anna Luise Weber; Birgit Gerisch; Adam Antebi
Journal:  Nat Metab       Date:  2020-05-18

Review 10.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.